Page last updated: 2024-10-30

mecamylamine and Paralysis

mecamylamine has been researched along with Paralysis in 1 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SACHAR, DB1

Other Studies

1 other study available for mecamylamine and Paralysis

ArticleYear
TOXIC REACTIONS TO LOW DOSES OF AMBENONIUM CHLORIDE; REPORT OF TWO CASES.
    The New England journal of medicine, 1964, Dec-10, Volume: 271

    Topics: Ambenonium Chloride; Atropine; Drug Therapy; Gastrointestinal Motility; Geriatrics; Humans; Mecamyla

1964